The Potential Clinical and Economic Outcomes of Pharmacogenomic Approaches to EGFR-Tyrosine Kinase Inhibitor Therapy in Non-Small-Cell Lung Cancer. - Carlson JJ; Garrison LP; Ramsey SD; Veenstra DL (Value in Health, 2009)